Updated time: 2022-06-23 10:30:20
12A-1070629
2020-05-20
TW I730450、 US 11286304 B2 , CN patent applications filed
Galectin-7 is a protein highly expressed by the skin keratinocytes and epithelial cells. Our research indicates that the expression of galectin-7 is inversely related to the development of psoriasis and progression of certain cancers. We further found a group of drugs employed for treatment of metabolic disorders can induce galectin-7. We developed antibodies and kits to screen for drugs or drug combinations that can be used to treat psoriasis or inhibit the progression of certain cancers.
- The content of this patent relates to a novel antibody that can exhibit binding affinity and specificity for galectin-7
- Use this novel antibody for drug screening to treat individuals with psoriasis or cancer.
- About a pharmaceutical composition test, and its use in the treatment of psoriasis or cancer.
Liu, Fu-Tong
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

The application of metabolic drug in inducing galectin-7 expression in keratinocytes